Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 12/2007

01-12-2007 | Erratum

A meta-analysis of exercise interventions among people treated for cancer

Authors: Vicki S. Conn, Adam R. Hafdahl, Davina C. Porock, Roxanne McDaniel, Paul J. Nielsen

Published in: Supportive Care in Cancer | Issue 12/2007

Login to get access

Excerpt

Erratum to: Support Care Cancer DOI 10.1007/s00520-005-0905-5 …
Metadata
Title
A meta-analysis of exercise interventions among people treated for cancer
Authors
Vicki S. Conn
Adam R. Hafdahl
Davina C. Porock
Roxanne McDaniel
Paul J. Nielsen
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 12/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0326-8

Other articles of this Issue 12/2007

Supportive Care in Cancer 12/2007 Go to the issue

Original Article

Endocrine symptom assessment in women with breast cancer: what a simple “yes” means

Review Article

Diagnosis and management of hyponatremia in cancer patients

Original Article

Dying at home or in an institution: perspectives of Dutch physicians and bereaved relatives

Supportive Care International

A population-based study on the specific locations of cancer deaths in Taiwan, 1997–2003

Original Article

An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy

Original Article

Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits